Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Natalizumab treatment for multiple sclerosis.
The Blood-Brain Barrier in Multiple Sclerosis: MicroRNAs as Key Regulators.
Peripheral late reactivation of a previously typical monofocal Baló's concentric sclerosis lesion.
The radiologically isolated syndrome dilemma: just an incidental radiological finding or presymptomatic multiple sclerosis?
NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG.
Exercise barriers and preferences among women and men with multiple sclerosis.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
Increased S-nitrosothiols are associated with spinal cord injury in multiple sclerosis.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Inter-hemispheric functional connectivity changes with corpus callosum morphology in multiple sclerosis.
Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy.
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
Multiple sclerosis and pregnancy: therapeutic considerations.
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.
How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis?
RA: from risk factors and pathogenesis to prevention: Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Vitamin D in autoimmune liver disease.
Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
The role of the community nurse in care provision for people with multiple sclerosis.
Vaccine against autoimmune disease: can helminths or their products provide a therapy?
Secondary hemophagocytic lymphohistiocytosis possibly induced by interferon beta-1a therapy.
Optic coherence tomography findings in relapsing-remitting multiple sclerosis patients of the northwest of Iran.
Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
Pages
« first
‹ previous
…
426
427
428
429
430
431
432
433
434
…
next ›
last »